What's Happening?
The American Lung Association is organizing its 11th annual LUNG FORCE Advocacy Day on March 25, where over 50 individuals affected by lung cancer will meet with members of Congress in Washington, D.C. These advocates, including survivors and caregivers,
aim to secure $51.3 billion in research funding for the National Institutes of Health (NIH) and $11.6 billion for the Centers for Disease Control and Prevention (CDC). The initiative seeks to enhance access to quality, affordable healthcare and improve lung cancer survival rates. The American Lung Association emphasizes the importance of continued federal support to develop new treatments and preventive measures, highlighting a 26% increase in the five-year survival rate over the past five years.
Why It's Important?
Lung cancer remains the leading cause of cancer-related deaths in the United States, making the advocacy for increased research funding crucial. The American Lung Association's efforts aim to sustain and enhance the progress made in lung cancer treatment and prevention. By securing federal funding, the organization hopes to drive further advancements in medical research, potentially leading to more effective treatments and higher survival rates. This initiative also underscores the broader need for accessible healthcare, which is vital for early detection and treatment of lung cancer, ultimately benefiting patients and reducing the overall healthcare burden.
What's Next?
Following the advocacy day, the American Lung Association will continue to engage with lawmakers to ensure sustained support for lung cancer research and healthcare access. The organization encourages public participation by urging individuals to contact their senators and representatives to advocate for the proposed funding. The outcome of these efforts could influence future legislative decisions regarding healthcare funding and cancer research priorities, potentially impacting millions of Americans affected by lung cancer.
